Skip to main content
. Author manuscript; available in PMC: 2010 May 11.
Published in final edited form as: Inhal Toxicol. 2009 Feb;21(3):223–233. doi: 10.1080/08958370802492407

TABLE 1.

Heart rate variability, exposure to 10 µg/m3 at rest, difference from baselinea

ECG parameter/
exposure
During
exposure
Hours after exposure
ANOVA
0 3.5 15 21
RR (msec)
    Air 20 ± 42 169 ± 34 –4 ± 25 80 ± 48 –34 ± 39 NS
    UFP 16 ± 40 140 ± 31 –37 ± 45 71 ± 28 0.6 ± 21
SDNN (msec)
    Air 29 ± 12 16 ± 17 –7 ± 8 0 ± 9 –6 ± 11 NS
    UFP 35 ± 13 26 ± 8 13 ± 12 2 ± 17 33 ± 12
rMSSD (msec)
    Air 19 ± 15 20 ± 21 –10 ± 9 8 ± 10 –13 ± 11 UFP × time: p = 0.032
    UFP 31 ± 19 27 ± 9 2 ± 11 9 ± 22 25 ± 12
Low frequency (Hz)
    Air 1411 ± 707 1213 ± 1435 –401 ± 511 366 ± 529 –228 ± 791 NS
    UFP 1692 ± 449 693 ± 336 508 ± 321 458 ± 635 833 ± 482
High frequency (Hz)
    Air 2022 ± 1706 672 ± 1665 –917 ± 680 686 ± 537 –1188 ± 925 NS
    UFP 2566 ± 1459 1315 ± 696 44 ± 779 1022 ± 1655 2407 ± 1261
Low frequency/high frequency
    Air 0.68 ± 0.45 –0.46 ± 0.29 0.15 ± 0.25 0.12 ± 0.59 0.42 ± 0.42 NS
    UFP 0.30 ± 0.23 –0.28 ± 0.24 0.31 ± 0.58 0.10 ± 0.31 –0.03 ± 0.17
a

Data are means ± SE.